Abnormal Uterine Bleeding Evaluation Note
A structured evaluation note for abnormal uterine bleeding in nonpregnant patients, emphasizing safety assessment, pregnancy exclusion, FIGO-based bleeding pattern characterization, and PALM-COEIN differential diagnosis…
Document Type
clinical note / Diagnostic Evaluation Note
Specialties
Template Preview
[Encounter date and time]
[Note author and role]
[Location]
[Source of history and reliability assessment]
[Interpreter: language and modality]
(Only include if interpreter was used)[Chaperone: name and role]
(Only include if chaperone was present)Chief Complaint
"[Chief complaint in patient's own words]" (One line; quote if brief. If multiple concerns, list bleeding complaint first.)
Safety Assessment
[Hemodynamic status summary]
(For stable patients with mild symptoms, condense to a single sentence confirming stability and absence of emergent features. For moderate-to-severe or acute bleeding, include details below.)- [Vital signs including orthostatics if dizziness, syncope, or significant blood loss suspected]
- [General appearance and perfusion status]
- [Red flag assessment: syncope/presyncope, chest pain, dyspnea, severe weakness, severe pelvic pain, fever, continuous flooding, known bleeding disorder, anticoagulant use]
- [Immediate interventions and rationale]
Pregnancy Exclusion
LMP: [Date / unknown]
Sexual activity and contraception context: [Brief summary]
Pregnancy test: [urine / serum], [result], [date/time performed]
[Pregnancy test not obtained: specific reason and clinician rationale; alternative plan or precautions reviewed]
(Only include if pregnancy testing not performed due to patient declined, prior hysterectomy, confirmed menopause, or other documented reason.)History of Present Illness
[Narrative summary of bleeding concern including onset, duration, progression, context, modifying factors, and functional impact]
Bleeding characterization: [Cycle length/frequency], [duration of episodes], [regularity/predictability], [flow volume with quantification: pad/tampon counts, overnight changes, clot size, flooding, functional interference], [intermenstrual bleeding pattern], [postcoital bleeding], [unscheduled bleeding on hormonal method with adherence assessment]
Anemia symptom inventory: [Lightheadedness/presyncope], [fatigue], [exertional dyspnea], [palpitations], [prior anemia or iron therapy], [transfusion history]
Associated gynecologic symptoms: [Pelvic pain or pressure], [dysmenorrhea severity], [bulk symptoms], [dyspareunia]
Gynecologic background: [Menarche age] (especially for adolescents), [baseline cycle pattern before current problem], [recent pregnancy or pregnancy loss], [contraception history], [future fertility goals]
Medical contributors and medications: [Anticoagulants/antiplatelets with dose and indication], [hormonal therapies with dose and adherence], [thyroid symptoms or history], [PCOS features if present], [relevant systemic diseases: liver, renal, hematologic]
Bleeding disorder screen: [Easy bruising], [epistaxis], [gum bleeding], [postpartum hemorrhage], [surgical/dental bleeding complications], [known coagulopathy], [family history of bleeding disorders]
(Include when heavy bleeding since menarche or personal/family bleeding history suggests coagulopathy.)Review of Systems
[Targeted ROS findings: constitutional, cardiopulmonary, endocrine, hematologic, GI/hepatic, GU/pelvic]
(Include only systems relevant to differential and workup.)[ROS not obtained: reason]
(Only include if ROS deferred.)Past Medical and Surgical History
- Medical: [Anemia, bleeding disorders, endocrine disorders, thromboembolism history or risk factors, other relevant conditions]
- Surgical: [Uterine/cervical procedures, other relevant surgeries]
- Medications: [Current medications; include dose and adherence for hormones and anticoagulants]
- Allergies: [Drug and non-drug allergies with reaction type]
- Family history: [Bleeding disorders, gynecologic malignancies with age at diagnosis]
- Social history: [Tobacco use status]
Physical Examination
Vitals: [BP, HR, RR, Temp, SpO2] (Include orthostatics when indicated.)
General: [Appearance, pallor, distress level]
Abdominal: [Tenderness, masses, distension, peritoneal signs]
Pelvic exam: [Consent obtained; chaperone present]
- External genitalia: [Findings]
- Speculum: [Source of bleeding: cervical vs uterine], [lesions], [discharge], [cervical findings]
- Bimanual: [Uterine size/contour], [tenderness], [adnexal findings], [cervical motion tenderness]
[Pelvic exam deferred: specific reason; alternative evaluation plan]
(Only include if deferred due to patient preference, age/indication, telehealth, or trauma history.)Diagnostics
Completed Today
- Pregnancy test: [Type, result, time] (Required when pregnancy is possible.)
- CBC: [Result summary and interpretation regarding anemia severity]
- Type and screen: [Result] (Include if severe bleeding or symptomatic anemia.)
- Directed labs: [Test, indication, result, interpretation] (Include coagulation/VWD testing, thyroid, STI, or endocrine studies based on clinical indications.)
- Imaging: [Pelvic ultrasound: TV/TA components, findings, interpretation]
Previously Available
- [Test type, date, source, pertinent results/interpretation]
Ordered Today (Pending)
- [Labs ordered with indication]
- [Imaging ordered with indication] (Consider sonohysterography or hysteroscopy if intracavitary pathology suspected; MRI for surgical planning.)
Endometrial Evaluation
Indication: [Age ≥45 / risk factors for hyperplasia / persistent bleeding / failed medical therapy / concerning imaging]
Method: [Office biopsy / hysteroscopy-directed] with rationale
Deferred: [Reason and timing plan]
(Only include if endometrial sampling not performed; document specific rationale.)Assessment
[2-4 sentence summary synthesizing: bleeding pattern characterization, pregnancy exclusion status, hemodynamic stability and anemia severity, and leading suspected etiologies. Use "suspected" unless imaging or pathology confirms diagnosis.]
Differential diagnosis (PALM-COEIN):
(Include only clinically relevant categories with supporting/opposing features and clarifying workup.)- Structural (PALM): [Polyp, Adenomyosis, Leiomyoma, Malignancy/hyperplasia considerations with evidence for/against]
- Non-structural (COEIN): [Coagulopathy, Ovulatory dysfunction, Endometrial, Iatrogenic, Not otherwise classified considerations with evidence for/against]
Plan
-
Abnormal Uterine Bleeding
- Stabilization: [IV access/fluids, medical options considered, contraindications assessed, escalation criteria] (Include for acute or moderate-severe presentations.)
- Diagnostic plan: [Labs, imaging, endometrial sampling with indications and timing]
- Maintenance therapy: [Selected treatment: LNG-IUS / tranexamic acid / NSAIDs / combined hormonal contraception / cyclic progestogens / other] based on [suspected cause and fertility goals]; contraindications screening and shared decision-making documented
- Structural pathology management: [Procedural options, consults, referrals] (Include if structural pathology confirmed or highly suspected.)
- Self-monitoring: Bleeding diary recommended
-
Iron Deficiency/Anemia
(Include if present.)- [CBC interpretation and severity classification]
- [Iron repletion: oral vs IV; dose, frequency, duration]
- [Follow-up labs: timing for hemoglobin/ferritin reassessment]
-
Contraception/Reproductive Goals
(Include when relevant.)- [Pregnancy intentions]
- [Contraception plan aligned with AUB therapy; contraindication screening documented]
Return Precautions and Follow-up
Emergency precautions: Return immediately for soaking pads/tampons hourly, syncope, chest pain, dyspnea, worsening weakness, severe pelvic pain, or fever.
Follow-up: [24-72 hours for acute presentations / 2-12 weeks for chronic AUB] (Specify exact timing based on acuity and treatment plan.)
Procedures
(Include this section only if a procedure was performed.)- Procedure: [Endometrial biopsy / IUD placement / other]
- Indication: [Clinical indication]
- Consent: [Risks, benefits, alternatives discussed; patient consented]
- Technique: [Anesthesia, preparation, steps, devices, findings]
- Specimens: [Description and destination]
- Complications: [None / details]
- Post-procedure instructions: [Care, activity restrictions, warning signs]
Want to use this template?
Copy it into your workflow, or book a demo to see Augustun draft notes like this automatically.